APO Research

APO RESEARCH · REPORT

Short Acting Contraceptives

Selected research

Market Analysis & Forecast

Global Short Acting Contraceptives Market Analysis and Forecast 2026-2032

Market perspective

The global Short Acting Contraceptives market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Short Acting Contraceptives is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Short Acting Contraceptives is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Short Acting Contraceptives is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Short Acting Contraceptives is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Short Acting Contraceptives include Bayer AG, China Resources Zizhu Pharmaceutical, Wyeth, Organon, Sichuan Chuanda Huaxi and Zhejiang Xianju, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Short Acting Contraceptives, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Short Acting Contraceptives, also provides the sales of main regions and countries. Of the upcoming market potential for Short Acting Contraceptives, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Short Acting Contraceptives sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Short Acting Contraceptives market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Short Acting Contraceptives sales, projected growth trends, production technology, application and end-user industry.

Short Acting Contraceptives Segment by Company

Bayer AG

China Resources Zizhu Pharmaceutical

Wyeth

Organon

Sichuan Chuanda Huaxi

Zhejiang Xianju

Short Acting Contraceptives Segment by Type

21 Tablets/Box

28 Tablets/Box (With Placebo)

Short Acting Contraceptives Segment by Application

Contraception

Hormone Regulation

Others

Short Acting Contraceptives Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Short Acting Contraceptives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Short Acting Contraceptives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Short Acting Contraceptives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Short Acting Contraceptives in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Short Acting Contraceptives manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Short Acting Contraceptives sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Short Acting Contraceptives Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 21 Tablets/Box Major Manufacturers Table 3. 28 Tablets/Box (With Placebo) Major Manufacturers Table 4. Global Short Acting Contraceptives Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Contraception Major Manufacturers Table 6. Hormone Regulation Major Manufacturers Table 7. Others Major Manufacturers Table 8. Short Acting Contraceptives Industry Trends Table 9. Short Acting Contraceptives Industry Drivers Table 10. Short Acting Contraceptives Industry Opportunities and Challenges Table 11. Short Acting Contraceptives Industry Restraints Table 12. Global Short Acting Contraceptives Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Short Acting Contraceptives Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Short Acting Contraceptives Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Short Acting Contraceptives Revenue Market Share by Region (2021-2026) Table 16. Global Short Acting Contraceptives Revenue Market Share by Region (2027-2032) Table 17. Global Short Acting Contraceptives Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Short Acting Contraceptives Sales by Region (2021-2026) & (K Units) Table 19. Global Short Acting Contraceptives Sales by Region (2027-2032) & (K Units) Table 20. Global Short Acting Contraceptives Sales Market Share by Region (2021-2026) Table 21. Global Short Acting Contraceptives Sales Market Share by Region (2027-2032) Table 22. Global Short Acting Contraceptives Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Short Acting Contraceptives Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Short Acting Contraceptives Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Short Acting Contraceptives Sales Market Share by Manufacturers (2021-2026) Table 26. Global Short Acting Contraceptives Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Short Acting Contraceptives Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Short Acting Contraceptives Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Short Acting Contraceptives Manufacturers, Product Type & Application Table 30. Global Short Acting Contraceptives Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Short Acting Contraceptives by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Short Acting Contraceptives Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Short Acting Contraceptives Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Short Acting Contraceptives Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Short Acting Contraceptives Revenue Market Share by Type (2021-2026) Table 37. Global Short Acting Contraceptives Revenue Market Share by Type (2027-2032) Table 38. Global Short Acting Contraceptives Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Short Acting Contraceptives Sales by Type (2021-2026) & (K Units) Table 40. Global Short Acting Contraceptives Sales by Type (2027-2032) & (K Units) Table 41. Global Short Acting Contraceptives Sales Market Share by Type (2021-2026) Table 42. Global Short Acting Contraceptives Sales Market Share by Type (2027-2032) Table 43. Global Short Acting Contraceptives Price by Type (2021-2026) & (US$/Unit) Table 44. Global Short Acting Contraceptives Price by Type (2027-2032) & (US$/Unit) Table 45. Global Short Acting Contraceptives Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Short Acting Contraceptives Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Short Acting Contraceptives Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Short Acting Contraceptives Revenue Market Share by Application (2021-2026) Table 49. Global Short Acting Contraceptives Revenue Market Share by Application (2027-2032) Table 50. Global Short Acting Contraceptives Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Short Acting Contraceptives Sales by Application (2021-2026) & (K Units) Table 52. Global Short Acting Contraceptives Sales by Application (2027-2032) & (K Units) Table 53. Global Short Acting Contraceptives Sales Market Share by Application (2021-2026) Table 54. Global Short Acting Contraceptives Sales Market Share by Application (2027-2032) Table 55. Global Short Acting Contraceptives Price by Application (2021-2026) & (US$/Unit) Table 56. Global Short Acting Contraceptives Price by Application (2027-2032) & (US$/Unit) Table 57. Bayer AG Company Information Table 58. Bayer AG Business Overview Table 59. Bayer AG Short Acting Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Bayer AG Short Acting Contraceptives Product Portfolio Table 61. Bayer AG Recent Development Table 62. China Resources Zizhu Pharmaceutical Company Information Table 63. China Resources Zizhu Pharmaceutical Business Overview Table 64. China Resources Zizhu Pharmaceutical Short Acting Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. China Resources Zizhu Pharmaceutical Short Acting Contraceptives Product Portfolio Table 66. China Resources Zizhu Pharmaceutical Recent Development Table 67. Wyeth Company Information Table 68. Wyeth Business Overview Table 69. Wyeth Short Acting Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Wyeth Short Acting Contraceptives Product Portfolio Table 71. Wyeth Recent Development Table 72. Organon Company Information Table 73. Organon Business Overview Table 74. Organon Short Acting Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Organon Short Acting Contraceptives Product Portfolio Table 76. Organon Recent Development Table 77. Sichuan Chuanda Huaxi Company Information Table 78. Sichuan Chuanda Huaxi Business Overview Table 79. Sichuan Chuanda Huaxi Short Acting Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Sichuan Chuanda Huaxi Short Acting Contraceptives Product Portfolio Table 81. Sichuan Chuanda Huaxi Recent Development Table 82. Zhejiang Xianju Company Information Table 83. Zhejiang Xianju Business Overview Table 84. Zhejiang Xianju Short Acting Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Zhejiang Xianju Short Acting Contraceptives Product Portfolio Table 86. Zhejiang Xianju Recent Development Table 87. North America Short Acting Contraceptives Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Short Acting Contraceptives Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Short Acting Contraceptives Sales by Type (2021-2026) & (K Units) Table 90. North America Short Acting Contraceptives Sales by Type (2027-2032) & (K Units) Table 91. North America Short Acting Contraceptives Sales Price by Type (2021-2026) & (US$/Unit) Table 92. North America Short Acting Contraceptives Sales Price by Type (2027-2032) & (US$/Unit) Table 93. North America Short Acting Contraceptives Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Short Acting Contraceptives Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Short Acting Contraceptives Sales by Application (2021-2026) & (K Units) Table 96. North America Short Acting Contraceptives Sales by Application (2027-2032) & (K Units) Table 97. North America Short Acting Contraceptives Sales Price by Application (2021-2026) & (US$/Unit) Table 98. North America Short Acting Contraceptives Sales Price by Application (2027-2032) & (US$/Unit) Table 99. North America Short Acting Contraceptives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Short Acting Contraceptives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 101. North America Short Acting Contraceptives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 102. North America Short Acting Contraceptives Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 103. North America Short Acting Contraceptives Sales by Country (2021-2026) & (K Units) Table 104. North America Short Acting Contraceptives Sales by Country (2027-2032) & (K Units) Table 105. North America Short Acting Contraceptives Sales Price by Country (2021-2026) & (US$/Unit) Table 106. North America Short Acting Contraceptives Sales Price by Country (2027-2032) & (US$/Unit) Table 107. United States Short Acting Contraceptives Revenue (2021-2032) & (US$ Million) Table 108. Canada Short Acting Contraceptives Revenue (2021-2032) & (US$ Million) Table 109. Europe Short Acting Contraceptives Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe Short Acting Contraceptives Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe Short Acting Contraceptives Sales by Type (2021-2026) & (K Units) Table 112. Europe Short Acting Contraceptives Sales by Type (2027-2032) & (K Units) Table 113. Europe Short Acting Contraceptives Sales Price by Type (2021-2026) & (US$/Unit) Table 114. Europe Short Acting Contraceptives Sales Price by Type (2027-2032) & (US$/Unit) Table 115. Europe Short Acting Contraceptives Revenue by Application (2021-2026) & (US$ Million) Table 116. Europe Short Acting Contraceptives Revenue by Application (2027-2032) & (US$ Million) Table 117. Europe Short Acting Contraceptives Sales by Application (2021-2026) & (K Units) Table 118. Europe Short Acting Contraceptives Sales by Application (2027-2032) & (K Units) Table 119. Europe Short Acting Contraceptives Sales Price by Application (2021-2026) & (US$/Unit) Table 120. Europe Short Acting Contraceptives Sales Price by Application (2027-2032) & (US$/Unit) Table 121. Europe Short Acting Contraceptives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Short Acting Contraceptives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. Europe Short Acting Contraceptives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. Europe Short Acting Contraceptives Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 125. Europe Short Acting Contraceptives Sales by Country (2021-2026) & (K Units) Table 126. Europe Short Acting Contraceptives Sales by Country (2027-2032) & (K Units) Table 127. Europe Short Acting Contraceptives Sales Price by Country (2021-2026) & (US$/Unit) Table 128. Europe Short Acting Contraceptives Sales Price by Country (2027-2032) & (US$/Unit) Table 129. Germany Short Acting Contraceptives Revenue (2021-2032) & (US$ Million) Table 130. France Short Acting Contraceptives Revenue (2021-2032) & (US$ Million) Table 131. U.K. Short Acting Contraceptives Revenue (2021-2032) & (US$ Million) Table 132. Italy Short Acting Contraceptives Revenue (2021-2032) & (US$ Million) Table 133. Netherlands Short Acting Contraceptives Revenue (2021-2032) & (US$ Million) Table 134. China Short Acting Contraceptives Revenue by Type (2021-2026) & (US$ Million) Table 135. China Short Acting Contraceptives Revenue by Type (2027-2032) & (US$ Million) Table 136. China Short Acting Contraceptives Sales by Type (2021-2026) & (K Units) Table 137. China Short Acting Contraceptives Sales by Type (2027-2032) & (K Units) Table 138. China Short Acting Contraceptives Sales Price by Type (2021-2026) & (US$/Unit) Table 139. China Short Acting Contraceptives Sales Price by Type (2027-2032) & (US$/Unit) Table 140. China Short Acting Contraceptives Revenue by Application (2021-2026) & (US$ Million) Table 141. China Short Acting Contraceptives Revenue by Application (2027-2032) & (US$ Million) Table 142. China Short Acting Contraceptives Sales by Application (2021-2026) & (K Units) Table 143. China Short Acting Contraceptives Sales by Application (2027-2032) & (K Units) Table 144. China Short Acting Contraceptives Sales Price by Application (2021-2026) & (US$/Unit) Table 145. China Short Acting Contraceptives Sales Price by Application (2027-2032) & (US$/Unit) Table 146. Asia Short Acting Contraceptives Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia Short Acting Contraceptives Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia Short Acting Contraceptives Sales by Type (2021-2026) & (K Units) Table 149. Asia Short Acting Contraceptives Sales by Type (2027-2032) & (K Units) Table 150. Asia Short Acting Contraceptives Sales Price by Type (2021-2026) & (US$/Unit) Table 151. Asia Short Acting Contraceptives Sales Price by Type (2027-2032) & (US$/Unit) Table 152. Asia Short Acting Contraceptives Revenue by Application (2021-2026) & (US$ Million) Table 153. Asia Short Acting Contraceptives Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia Short Acting Contraceptives Sales by Application (2021-2026) & (K Units) Table 155. Asia Short Acting Contraceptives Sales by Application (2027-2032) & (K Units) Table 156. Asia Short Acting Contraceptives Sales Price by Application (2021-2026) & (US$/Unit) Table 157. Asia Short Acting Contraceptives Sales Price by Application (2027-2032) & (US$/Unit) Table 158. Asia Short Acting Contraceptives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia Short Acting Contraceptives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Asia Short Acting Contraceptives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Asia Short Acting Contraceptives Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 162. Asia Short Acting Contraceptives Sales by Country (2021-2026) & (K Units) Table 163. Asia Short Acting Contraceptives Sales by Country (2027-2032) & (K Units) Table 164. Asia Short Acting Contraceptives Sales Price by Country (2021-2026) & (US$/Unit) Table 165. Asia Short Acting Contraceptives Sales Price by Country (2027-2032) & (US$/Unit) Table 166. Japan Short Acting Contraceptives Revenue (2021-2032) & (US$ Million) Table 167. South Korea Short Acting Contraceptives Revenue (2021-2032) & (US$ Million) Table 168. India Short Acting Contraceptives Revenue (2021-2032) & (US$ Million) Table 169. Australia Short Acting Contraceptives Revenue (2021-2032) & (US$ Million) Table 170. China Taiwan Short Acting Contraceptives Revenue (2021-2032) & (US$ Million) Table 171. Southeast Asia Short Acting Contraceptives Revenue (2021-2032) & (US$ Million) Table 172. SAMEA Short Acting Contraceptives Revenue by Type (2021-2026) & (US$ Million) Table 173. SAMEA Short Acting Contraceptives Revenue by Type (2027-2032) & (US$ Million) Table 174. SAMEA Short Acting Contraceptives Sales by Type (2021-2026) & (K Units) Table 175. SAMEA Short Acting Contraceptives Sales by Type (2027-2032) & (K Units) Table 176. SAMEA Short Acting Contraceptives Sales Price by Type (2021-2026) & (US$/Unit) Table 177. SAMEA Short Acting Contraceptives Sales Price by Type (2027-2032) & (US$/Unit) Table 178. SAMEA Short Acting Contraceptives Revenue by Application (2021-2026) & (US$ Million) Table 179. SAMEA Short Acting Contraceptives Revenue by Application (2027-2032) & (US$ Million) Table 180. SAMEA Short Acting Contraceptives Sales by Application (2021-2026) & (K Units) Table 181. SAMEA Short Acting Contraceptives Sales by Application (2027-2032) & (K Units) Table 182. SAMEA Short Acting Contraceptives Sales Price by Application (2021-2026) & (US$/Unit) Table 183. SAMEA Short Acting Contraceptives Sales Price by Application (2027-2032) & (US$/Unit) Table 184. SAMEA Short Acting Contraceptives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. SAMEA Short Acting Contraceptives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. SAMEA Short Acting Contraceptives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. SAMEA Short Acting Contraceptives Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 188. SAMEA Short Acting Contraceptives Sales by Country (2021-2026) & (K Units) Table 189. SAMEA Short Acting Contraceptives Sales by Country (2027-2032) & (K Units) Table 190. SAMEA Short Acting Contraceptives Sales Price by Country (2021-2026) & (US$/Unit) Table 191. SAMEA Short Acting Contraceptives Sales Price by Country (2027-2032) & (US$/Unit) Table 192. Brazil Short Acting Contraceptives Revenue (2021-2032) & (US$ Million) Table 193. Argentina Short Acting Contraceptives Revenue (2021-2032) & (US$ Million) Table 194. Chile Short Acting Contraceptives Revenue (2021-2032) & (US$ Million) Table 195. Colombia Short Acting Contraceptives Revenue (2021-2032) & (US$ Million) Table 196. Peru Short Acting Contraceptives Revenue (2021-2032) & (US$ Million) Table 197. Saudi Arabia Short Acting Contraceptives Revenue (2021-2032) & (US$ Million) Table 198. Israel Short Acting Contraceptives Revenue (2021-2032) & (US$ Million) Table 199. UAE Short Acting Contraceptives Revenue (2021-2032) & (US$ Million) Table 200. Turkey Short Acting Contraceptives Revenue (2021-2032) & (US$ Million) Table 201. Iran Short Acting Contraceptives Revenue (2021-2032) & (US$ Million) Table 202. Egypt Short Acting Contraceptives Revenue (2021-2032) & (US$ Million) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Short Acting Contraceptives Distributors List Table 206. Short Acting Contraceptives Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Short Acting Contraceptives Image Figure 2. Global Short Acting Contraceptives Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Short Acting Contraceptives Market Size Share 2021 VS 2025 VS 2032 Figure 4. 21 Tablets/Box Image Figure 5. 28 Tablets/Box (With Placebo) Image Figure 6. Global Short Acting Contraceptives Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Short Acting Contraceptives Market Size Share 2021 VS 2025 VS 2032 Figure 8. Contraception Image Figure 9. Hormone Regulation Image Figure 10. Others Image Figure 11. Global Short Acting Contraceptives Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Short Acting Contraceptives Revenue (2021-2032) & (US$ Million) Figure 13. Global Short Acting Contraceptives Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Short Acting Contraceptives Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Short Acting Contraceptives Revenue Market Share by Region (2021-2032) Figure 16. Global Short Acting Contraceptives Sales (2021-2032) & (K Units) Figure 17. Global Short Acting Contraceptives Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Short Acting Contraceptives Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Short Acting Contraceptives Sales YoY (2021-2032) & (K Units) Figure 20. Europe Short Acting Contraceptives Sales YoY (2021-2032) & (K Units) Figure 21. China Short Acting Contraceptives Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Short Acting Contraceptives Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Short Acting Contraceptives Sales YoY (2021-2032) & (K Units) Figure 24. Global Short Acting Contraceptives Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Short Acting Contraceptives Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Short Acting Contraceptives Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Short Acting Contraceptives Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Short Acting Contraceptives Revenue Market Share by Type (2021-2032) Figure 30. Global Short Acting Contraceptives Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Short Acting Contraceptives Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Short Acting Contraceptives Sales Market Share by Type (2021-2032) Figure 33. Global Short Acting Contraceptives Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Short Acting Contraceptives Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Short Acting Contraceptives Revenue Market Share by Application (2021-2032) Figure 36. Global Short Acting Contraceptives Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Short Acting Contraceptives Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Short Acting Contraceptives Sales Market Share by Application (2021-2032) Figure 39. North America Short Acting Contraceptives Revenue Share by Type (2021-2032) Figure 40. North America Short Acting Contraceptives Sales Share by Type (2021-2032) Figure 41. North America Short Acting Contraceptives Revenue Share by Application (2021-2032) Figure 42. North America Short Acting Contraceptives Sales Share by Application (2021-2032) Figure 43. North America Short Acting Contraceptives Revenue Share by Country (2021-2032) Figure 44. North America Short Acting Contraceptives Sales Share by Country (2021-2032) Figure 45. Europe Short Acting Contraceptives Revenue Share by Type (2021-2032) Figure 46. Europe Short Acting Contraceptives Sales Share by Type (2021-2032) Figure 47. Europe Short Acting Contraceptives Revenue Share by Application (2021-2032) Figure 48. Europe Short Acting Contraceptives Sales Share by Application (2021-2032) Figure 49. Europe Short Acting Contraceptives Revenue Share by Country (2021-2032) Figure 50. Europe Short Acting Contraceptives Sales Share by Country (2021-2032) Figure 51. China Short Acting Contraceptives Revenue Share by Type (2021-2032) Figure 52. China Short Acting Contraceptives Sales Share by Type (2021-2032) Figure 53. China Short Acting Contraceptives Revenue Share by Application (2021-2032) Figure 54. China Short Acting Contraceptives Sales Share by Application (2021-2032) Figure 55. Asia Short Acting Contraceptives Revenue Share by Type (2021-2032) Figure 56. Asia Short Acting Contraceptives Sales Share by Type (2021-2032) Figure 57. Asia Short Acting Contraceptives Revenue Share by Application (2021-2032) Figure 58. Asia Short Acting Contraceptives Sales Share by Application (2021-2032) Figure 59. Asia Short Acting Contraceptives Revenue Share by Country (2021-2032) Figure 60. Asia Short Acting Contraceptives Sales Share by Country (2021-2032) Figure 61. SAMEA Short Acting Contraceptives Revenue Share by Type (2021-2032) Figure 62. SAMEA Short Acting Contraceptives Sales Share by Type (2021-2032) Figure 63. SAMEA Short Acting Contraceptives Revenue Share by Application (2021-2032) Figure 64. SAMEA Short Acting Contraceptives Sales Share by Application (2021-2032) Figure 65. SAMEA Short Acting Contraceptives Revenue Share by Country (2021-2032) Figure 66. SAMEA Short Acting Contraceptives Sales Share by Country (2021-2032) Figure 67. Short Acting Contraceptives Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Short Acting Contraceptives Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 21 Tablets/Box
  • 28 Tablets/Box (With Placebo)
Applications
  • Contraception
  • Hormone Regulation
  • Others
Companies covered
  • Bayer AG
  • China Resources Zizhu Pharmaceutical
  • Wyeth
  • Organon
  • Sichuan Chuanda Huaxi
  • Zhejiang Xianju

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Short Acting Contraceptives Market by Type
  3. 1.2.1 Global Short Acting Contraceptives Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 21 Tablets/Box
  5. 1.2.3 28 Tablets/Box (With Placebo)
  6. 1.3 Short Acting Contraceptives Market by Application
  7. 1.3.1 Global Short Acting Contraceptives Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Contraception
  9. 1.3.3 Hormone Regulation
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Short Acting Contraceptives Market Dynamics
  1. 2.1 Short Acting Contraceptives Industry Trends
  2. 2.2 Short Acting Contraceptives Industry Drivers
  3. 2.3 Short Acting Contraceptives Industry Opportunities and Challenges
  4. 2.4 Short Acting Contraceptives Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Short Acting Contraceptives Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Short Acting Contraceptives Revenue by Region
  3. 3.2.1 Global Short Acting Contraceptives Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Short Acting Contraceptives Revenue by Region (2021-2026)
  5. 3.2.3 Global Short Acting Contraceptives Revenue by Region (2027-2032)
  6. 3.2.4 Global Short Acting Contraceptives Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Short Acting Contraceptives Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Short Acting Contraceptives Sales by Region
  9. 3.4.1 Global Short Acting Contraceptives Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Short Acting Contraceptives Sales by Region (2021-2026)
  11. 3.4.3 Global Short Acting Contraceptives Sales by Region (2027-2032)
  12. 3.4.4 Global Short Acting Contraceptives Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Short Acting Contraceptives Revenue by Manufacturers
  2. 4.1.1 Global Short Acting Contraceptives Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Short Acting Contraceptives Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Short Acting Contraceptives Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Short Acting Contraceptives Sales by Manufacturers
  6. 4.2.1 Global Short Acting Contraceptives Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Short Acting Contraceptives Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Short Acting Contraceptives Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Short Acting Contraceptives Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Short Acting Contraceptives Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Short Acting Contraceptives Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Short Acting Contraceptives Manufacturers, Product Type & Application
  13. 4.7 Global Short Acting Contraceptives Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Short Acting Contraceptives Market CR5 and HHI
  16. 4.8.2 2025 Short Acting Contraceptives Tier 1, Tier 2, and Tier 3
5 Short Acting Contraceptives Market by Type
  1. 5.1 Global Short Acting Contraceptives Revenue by Type
  2. 5.1.1 Global Short Acting Contraceptives Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Short Acting Contraceptives Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Short Acting Contraceptives Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Short Acting Contraceptives Sales by Type
  6. 5.2.1 Global Short Acting Contraceptives Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Short Acting Contraceptives Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Short Acting Contraceptives Sales Market Share by Type (2021-2032)
  9. 5.3 Global Short Acting Contraceptives Price by Type
6 Short Acting Contraceptives Market by Application
  1. 6.1 Global Short Acting Contraceptives Revenue by Application
  2. 6.1.1 Global Short Acting Contraceptives Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Short Acting Contraceptives Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Short Acting Contraceptives Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Short Acting Contraceptives Sales by Application
  6. 6.2.1 Global Short Acting Contraceptives Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Short Acting Contraceptives Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Short Acting Contraceptives Sales Market Share by Application (2021-2032)
  9. 6.3 Global Short Acting Contraceptives Price by Application
7 Company Profiles
  1. 7.1 Bayer AG
  2. 7.1.1 Bayer AG Company Information
  3. 7.1.2 Bayer AG Business Overview
  4. 7.1.3 Bayer AG Short Acting Contraceptives Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bayer AG Short Acting Contraceptives Product Portfolio
  6. 7.1.5 Bayer AG Recent Developments
  7. 7.2 China Resources Zizhu Pharmaceutical
  8. 7.2.1 China Resources Zizhu Pharmaceutical Company Information
  9. 7.2.2 China Resources Zizhu Pharmaceutical Business Overview
  10. 7.2.3 China Resources Zizhu Pharmaceutical Short Acting Contraceptives Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 China Resources Zizhu Pharmaceutical Short Acting Contraceptives Product Portfolio
  12. 7.2.5 China Resources Zizhu Pharmaceutical Recent Developments
  13. 7.3 Wyeth
  14. 7.3.1 Wyeth Company Information
  15. 7.3.2 Wyeth Business Overview
  16. 7.3.3 Wyeth Short Acting Contraceptives Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Wyeth Short Acting Contraceptives Product Portfolio
  18. 7.3.5 Wyeth Recent Developments
  19. 7.4 Organon
  20. 7.4.1 Organon Company Information
  21. 7.4.2 Organon Business Overview
  22. 7.4.3 Organon Short Acting Contraceptives Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Organon Short Acting Contraceptives Product Portfolio
  24. 7.4.5 Organon Recent Developments
  25. 7.5 Sichuan Chuanda Huaxi
  26. 7.5.1 Sichuan Chuanda Huaxi Company Information
  27. 7.5.2 Sichuan Chuanda Huaxi Business Overview
  28. 7.5.3 Sichuan Chuanda Huaxi Short Acting Contraceptives Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sichuan Chuanda Huaxi Short Acting Contraceptives Product Portfolio
  30. 7.5.5 Sichuan Chuanda Huaxi Recent Developments
  31. 7.6 Zhejiang Xianju
  32. 7.6.1 Zhejiang Xianju Company Information
  33. 7.6.2 Zhejiang Xianju Business Overview
  34. 7.6.3 Zhejiang Xianju Short Acting Contraceptives Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Zhejiang Xianju Short Acting Contraceptives Product Portfolio
  36. 7.6.5 Zhejiang Xianju Recent Developments
8 North America
  1. 8.1 North America Short Acting Contraceptives Market Size by Type
  2. 8.1.1 North America Short Acting Contraceptives Revenue by Type (2021-2032)
  3. 8.1.2 North America Short Acting Contraceptives Sales by Type (2021-2032)
  4. 8.1.3 North America Short Acting Contraceptives Price by Type (2021-2032)
  5. 8.2 North America Short Acting Contraceptives Market Size by Application
  6. 8.2.1 North America Short Acting Contraceptives Revenue by Application (2021-2032)
  7. 8.2.2 North America Short Acting Contraceptives Sales by Application (2021-2032)
  8. 8.2.3 North America Short Acting Contraceptives Price by Application (2021-2032)
  9. 8.3 North America Short Acting Contraceptives Market Size by Country
  10. 8.3.1 North America Short Acting Contraceptives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Short Acting Contraceptives Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Short Acting Contraceptives Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Short Acting Contraceptives Market Size by Type
  2. 9.1.1 Europe Short Acting Contraceptives Revenue by Type (2021-2032)
  3. 9.1.2 Europe Short Acting Contraceptives Sales by Type (2021-2032)
  4. 9.1.3 Europe Short Acting Contraceptives Price by Type (2021-2032)
  5. 9.2 Europe Short Acting Contraceptives Market Size by Application
  6. 9.2.1 Europe Short Acting Contraceptives Revenue by Application (2021-2032)
  7. 9.2.2 Europe Short Acting Contraceptives Sales by Application (2021-2032)
  8. 9.2.3 Europe Short Acting Contraceptives Price by Application (2021-2032)
  9. 9.3 Europe Short Acting Contraceptives Market Size by Country
  10. 9.3.1 Europe Short Acting Contraceptives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Short Acting Contraceptives Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Short Acting Contraceptives Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Short Acting Contraceptives Market Size by Type
  2. 10.1.1 China Short Acting Contraceptives Revenue by Type (2021-2032)
  3. 10.1.2 China Short Acting Contraceptives Sales by Type (2021-2032)
  4. 10.1.3 China Short Acting Contraceptives Price by Type (2021-2032)
  5. 10.2 China Short Acting Contraceptives Market Size by Application
  6. 10.2.1 China Short Acting Contraceptives Revenue by Application (2021-2032)
  7. 10.2.2 China Short Acting Contraceptives Sales by Application (2021-2032)
  8. 10.2.3 China Short Acting Contraceptives Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Short Acting Contraceptives Market Size by Type
  2. 11.1.1 Asia Short Acting Contraceptives Revenue by Type (2021-2032)
  3. 11.1.2 Asia Short Acting Contraceptives Sales by Type (2021-2032)
  4. 11.1.3 Asia Short Acting Contraceptives Price by Type (2021-2032)
  5. 11.2 Asia Short Acting Contraceptives Market Size by Application
  6. 11.2.1 Asia Short Acting Contraceptives Revenue by Application (2021-2032)
  7. 11.2.2 Asia Short Acting Contraceptives Sales by Application (2021-2032)
  8. 11.2.3 Asia Short Acting Contraceptives Price by Application (2021-2032)
  9. 11.3 Asia Short Acting Contraceptives Market Size by Country
  10. 11.3.1 Asia Short Acting Contraceptives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Short Acting Contraceptives Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Short Acting Contraceptives Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Short Acting Contraceptives Market Size by Type
  2. 12.1.1 SAMEA Short Acting Contraceptives Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Short Acting Contraceptives Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Short Acting Contraceptives Price by Type (2021-2032)
  5. 12.2 SAMEA Short Acting Contraceptives Market Size by Application
  6. 12.2.1 SAMEA Short Acting Contraceptives Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Short Acting Contraceptives Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Short Acting Contraceptives Price by Application (2021-2032)
  9. 12.3 SAMEA Short Acting Contraceptives Market Size by Country
  10. 12.3.1 SAMEA Short Acting Contraceptives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Short Acting Contraceptives Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Short Acting Contraceptives Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Short Acting Contraceptives Value Chain Analysis
  2. 13.1.1 Short Acting Contraceptives Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Short Acting Contraceptives Production Mode & Process
  6. 13.2 Short Acting Contraceptives Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Short Acting Contraceptives Distributors
  9. 13.2.3 Short Acting Contraceptives Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research